Feed-Forward and Feed-Back Circuits of the NRF2/AP-1 Composite Pathway by Zolotukhin, Peter V. & Belanova, Anna A.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter 4
Feed-Forward and Feed-Back Circuits of the NRF2/AP-1
Composite Pathway
Peter V. Zolotukhin and Anna A. Belanova
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/65216
Provisional chapter
Feed-Forward and Feed-Back Circuits of the NRF2/AP-1
Composite Pathway
Peter V. Zolotukhin and Anna A. Belanova
Additional information is available at the end of the chapter
Abstract
Being the central regulator of oxidative status of the cell, NRF2 must be regulated so
that  its  activity  can  be  rapidly  and  strongly  induced  when  needed  and  quickly
suppressed  when  not.  Moreover,  for  the  cell,  NRF2  means  much  more  than  just
antioxidant defense. Numerous general functions rely on NRF2 and related factors. All
this implies that the NRF2 pathway has peculiar and powerful mechanisms of control
of its activity. To a great extent, these mechanisms are based on feed-forward and feed-
back circuits. These circuits, more than a dozen, are in the focus of this chapter.
Keywords: feed-back regulation, feed-forward regulation, SQSTM1, SESN2, thiore-
doxin, NF-kappaB, GSTP1, NAPDH oxidase, NRF1, NFE2L1, NRF3, NFE2L3, BACH1,
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1. Introduction
According to the study by Malhotra et al. [1], Nrf2 controls 1055 protein-coding genes in mice.
Although no similar study has ever been performed in humans and given that most routinely
studied Nrf2 targets are the same in humans and mice, it is a reasonable assumption that
roughly the same number of  protein-coding genes is  regulated by NRF2 in our species,
accounting for astonishing ~5% of all our protein-coding genes. This raises a question: how
does NRF2, being a well-known stand-by inducible transcription factor curbed in cytoplasm
by KEAP1, fit into cellular context with so many target genes? Among those numerous genes,
only a portion codes for immediate antioxidants and detoxifying enzymes. It is the more
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intriguing since central proteasomal [2], autophagic [3], general signaling [4, 5], and, moreover,
cell proliferation, cell cycle and survival regulation factors [1] are in fact NRF2 targets.
Although 645 of the 1055 Nrf2 target genes were found to have basal type of expression
regulation by this factor [1], Nrf2 is still required to be present in the nucleus in significant
amounts to drive their expression. Notably, most of these genes are not at all related to
antioxidant and xenobiotic defense systems, i.e., they are essential for proliferation and basic
functioning of the cell. Thus, basal expression driven by NRF2 is important for the cell, but to
what extent? One should bear in mind that NRF2 knockouts are nonlethal and generally
appear normal in stable laboratory conditions [6], yet they are susceptible to numerous
diseases [7–9], especially when the housing conditions are suboptimal [6, 10–12]. This confirms
that basal NRF2 functioning, although not vital, is critical for the cell and organism even when
no pro-oxidant or xenobiotic exposure is present.
It implies that some cellular mechanisms serve to provide the cell with at least minimal
necessary NRF2 activity. On the other hand, it is inherently important for an inducible
antioxidant and xenobiotic defense pathway to act as quickly as possible, thus signal amplifi-
cation is required whenever the initial stimulus is applied. These two distinct prerequisites for
normal cell functioning in ever-changing environment appear to be resolved in principle
similarly: there are feed-forward circuits that maintain steady-state level of the NRF2 activity
and make signal amplification possible when fast cellular reactions are required.
Conversely, too much NRF2 activity is no better than its absence: Keap1-null mice demonstrate
postnatal lethality [13, 14], an effect coinciding with nuclear Nrf2 localization [14] and reversed
by Nrf2 downregulation [13]. In this case, several feed-back circuits protect the cell and
organism from obsessive NRF2 activation.
Most of the feed-forward and feed-back circuits of the NRF2 pathway also involve the closely
related transcription factor activator protein 1 (AP-1) represented by homodimers of Jun
proteins (JUN, JUNB, JUND) or heterodimers of Fos (FOS, FOSB, FOSL1, FOSL2) and Jun
proteins. There are also other dimers of Jun/Fos proteins—e.g. with Atf-proteins [15–17]—still
referred to as AP-1 complexes (although either Jun or Fos proteins are absent), and oligomers
of Jun/Fos proteins with other proteins. NRF2, in line with NRF1, NRF3 and AP-1 proteins
(including Atf proteins) are all basic leucine zipper (bZip) transcription factors of similar
structure [18–20]. Functional roles and regulation of Nrf- and AP-1-proteins also significantly
overlap [21–24], and, what is even more, these two groups of proteins regulate each other at
several levels, including transcription control. It should be especially noted that NRF2 binding
site ARE and AP-1 binding site TRE often overlap with AP-1 being embedded into ARE [25,
26]. Having such tight relations, NRF2 and AP-1 obviously form a composite NRF2/AP-1 (or
NFE2L2/AP-1) pathway, with both factors contributing much to their own functioning via
shared feed-forward and feed-back circuits.
All feed-forward and feed-back circuits are represented, but not outlined or highlighted, in
oxidative status interactome map (OSIM) created in our laboratory [26]. This chapter, in
contrast, emphasizes on functioning of these circuits and their peculiarities.
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2. Feed-forward circuits
2.1. The SESN2/SQSTM1 circuit
In 2010, Copple et al., and in 2011, Bui and Shin independently demonstrated that the auto-
phagosomal adaptor protein SQSTM1 (also known as p62) is capable of activating the NRF2
pathway without oxidative modification of KEAP1 protein [27, 28]. This route of the NRF2
pathway activation is one of many known for today. And by the time of this important
discovery, it had already been known that SQSTM1 itself is a target gene of NRF2 [29]. Thus,
SQSTM1 was found to form a feed-forward circuit capable of noncanonical activation of NRF2.
The mode of action of this factor is in line with its primary function—it merely targets KEAP1
for autophagosomal degradation, and this process takes place in the cytoplasmic complex of
KEAP1 and NRF2 [27, 28]. Copple et al., of immediate relevance to this chapter, also showed
that Sqstm1-dependent activation of Nrf2 is responsible for ~50% of basal expression of
classical Nrf2/Ap-1 targets Nqo1, Gclc and classical Nrf2 target Hmox1 [27].
Later on, Bae et al. [30] revealed that, in mice, Sqstm1 actually promotes Keap1 degradation
when Sesn2 is available. A year before, Shin et al. found that Sesn2/SESN2 is also an Nrf2/NRF2
target (Figure 1) [31].
Figure 1. The SESN2/SQSTM1 circuit. Dashed line marks putative interaction.
To our knowledge, to date, there are no direct evidences that the same SESN2/SQSTM1 sys-
tem is required for KEAP1 degradation. However, considering evolutionary significance of
autophagy and, consequently, SQSTM1, it is highly possible that this holds true for humans
as it does for mice. It is also known that SESN2 works together with SQSTM1 in mitophagy,
an instance of autophagy [32]. As such, we ourselves have recently tested this hypothesis in
our laboratory using the RNA interference approach. We found that in basal conditions
SESN2 knockdown caused significant changes in expression of GCLC, HMOX1 and
SQSTM1 (all NRF2 targets tested in the study) [33]. Indirect observations emanating from
this study also suggest that actually BACH1 expression is also affected, and BACH1 forms a
peculiar feed-back circuit which will be discussed below. In the same study, in pro-oxidant
exposure conditions (modeled by culturing HeLa cells in medium containing 400 μM hy-
drogen peroxide for 24 h after the substance injection; 400 μM hydrogen peroxide was
found to be sublethal for HeLa cells in our previous study [34]), on the contrary, SESN2
knockdown caused less pronounced effect on expression of the same set of genes—only
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HMOX1 and SQSTM1 had significant changes in expression [33]. To the moment of prepa-
ration of this chapter, these data are in publication progress.
All together, the existing data clearly show that SESN2/SQSTM1 feed-forward circuit supports
basal expression of NRF2/AP-1 targets and to some extent fortifies inducible reaction of this
pathway.
2.2. The TXN feed-forward circuit
Thioredoxin 1, TXN, has long been known as a critical factor of activation of AP-1 transcription
factor [35–37]. This TXN role has an intermediate factor—a DNA repair enzyme and a
transcription factor DNA-binding promoter APEX1 [35, 36]. Interestingly, this protein is itself
activated by some stimuli that are within primary focus of the NRF2/AP-1 pathway, including
pro-oxidants and ionizing radiation [38], but excluding UV radiation [38], as is TXN nuclear
import [39, 40].
Figure 2. The TXN feed-forward circuit. Dashed line marks putative interaction.
Years later, Iwasaki et al. found that APEX1 actually facilitates DNA binding to expression of
target genes of NRF2 [23] in addition to those of AP-1, NF-kappaB and HIF1A [41]. The same
was also confirmed by Shan et al. [42]. As APEX1 reduction by TXN is obligate to its function
[37], TXN is a player in NRF2-driven expression, at least in some instances. In this sense, it
should be mentioned that the fact that TXN forces NRF2 binding to DNA may be due to direct
heterodimerization of Juns (e.g., JUND) with NRF2 [23, 43, 44], as it exactly is in case of
FTH1, which was the gene of interest in the study by Iwasaki et al. This raises the possibility
that at least in some cases TXN stimulates NRF2 binding to DNA when AP-1 partners are
present. Nevertheless, TXN stimulates the NRF2/AP-1 pathway activation.
At the same time, it has already been known for a long time that TXN expression is driven by
antioxidant responsive element [45, 46], and Kim et al. directly showed that thioredoxin forces
its own expression [22].
A Master Regulator of Oxidative Stress - The Transcription Factor Nrf268
TXN functioning as a transcription factor DNA-binding stimulator is conferred by its partici-
pation in disulfide-dithiol exchange reactions with APEX1. Once APEX1 has reduced itself in
expense of reduced TXN, TXN has to be reduced. There are two major reductases of TXN:
TXNRD1 [47] and TXNRD3 [48]. TXNRD1 is in fact an NRF2 target itself [49]. This makes the
TXN feed-forward circuit self-sufficient (Figure 2). We found no evidences that TXNRD3 is an
NRF2 target in human, although this is still plausible since this gene/protein is merely poorly
studied.
Thioredoxin feed-forward circuit is notable in one more sense: as TRE is often embedded in
ARE, one should always consider that an ARE-containing gene may in fact be regulated by
AP-1 binding to embedded TRE. This is exactly the case of thioredoxin 1: in their work, Kim
et al. found that Jun and Fos overexpression decreased TXN expression in K562 cells [22]. In
our work, we have also observed negative interactions between AP-1 and NRF2 working on
the same ARE (with embedded TRE) [34], and this mechanism appears to be cell-context
dependent, since NRF2 and AP-1 can have both positive and negative effects on the same genes
in different cells. This will be discussed in detail in the next section.
Interestingly, TXN feed-forward circuit appears to involve a mechanism of adjustment, which
is based on differential control of TXN transcripts. Among NRF2 targets, BACH1 was the first
to be described as having individual control of transcripts [50]. Later, we tested whether TXN
transcript variants are differentially expressed when the NRF2 pathway gets activated, and so
it was [51, 52]. This renders the TXN feed-forward circuit easily adjustable by the cell since
only one of the transcripts is NRF2/AP-1 dependent.
The existence of this feed-forward circuit was proven experimentally. However, there are at
least two more circuits in the NRF2/AP-1 pathway involving TXN, NRF2 and AP-1. One of
them is a mixed feed-forward/feed-back circuit depending on cellular context (discussed in
next section), whereas another is a feed-back circuit (discussed below with other feed-back
circuits).
2.3. The AP-1/TXN/NRF2 bidirectional circuit
As TXN is an NRF2 target, and TXN is required for AP-1 activation, it forms one more complex
circuit. This circuit cannot be considered as either purely feed forward or feed-back. In a set
of studies, it was shown that JUN, being a part of AP-1, controls expression of NRF2 [34, 53,
54]. The complexity is that JUN can both activate and suppress the NRF2 expression depending
on the cells analyzed: DeNicola et al. [53] demonstrated that, in murine MEF K-RasG12D cells,
Jun transactivates Nrf2, whereas Cho et al. [54] and our laboratory [34] showed that JUN has
negative influence on NRF2 expression.
Thus, in the cells that are featured by JUN activating NRF2, JUN stimulates expression of
NRF2, the latter activates expression of TXN, which, in turn, induces JUN DNA binding. In
this case, this circuit acts as feed-forward for both NRF2 and AP-1 (Figure 3A).
In contrast, in cells whose JUN suppresses NRF2, less TXN is expressed and that is less
favorable for AP-1 DNA binding, thus releasing suppression from NRF2 expression. Conse-
quently, in this case, the circuit acts as feed-back for AP-1, whereas feed-forward, to some
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extent, for NRF2 (Figure 3B). It appears that this system favors NRF2 functioning in basal
conditions, but acts to suppress it once NRF2 is activated. We ourselves observed the latter
situation [34] but have not yet tested the former.
Figure 3. The AP-1/TXN/NRF2 bidirectional circuit. Dashed line marks putative interaction. (A) depicts the situation
when cell signaling background determines the system of interaction between NRF2 and AP-1 to act as a feed-forward
circuit. On the other hand, (B) illustrates how these interactions form a feed-back circuit in other cell types or cellular
conditions.
How is this possible that this circuit differs this much in various cells? The simplest explanation
we would suggest is, different cell lines express different amounts of Fos proteins—FOS, FOSB,
FOSL1, FOSL2, as well as other Jun proteins—JUNB, JUND [22, 35, 55]. All these proteins
significantly differ in their effects on JUN. Moreover, how all Juns perform depends on the
presence of JUN dimerizing protein JDP2 capable of deactivating Juns by dimerizing them and
by epigenetically silencing the JUN gene [56]. Thus, immediate protein partners of JUN and
its powerful regulator JDP2 seem to determine whether JUN will activate or suppress the NRF2
expression in a given cell line. However, this is to be tested in upcoming studies.
2.4. The GSTP1 feed-forward circuit
One of the well-known NRF2 targets, GSTP1 [57, 58], has recently been found to form a novel
feed-forward circuit of the NRF2/AP-1 pathway. Carvalho et al. have just recently revealed
that, in mice, Gstp1 is capable of S-glutathionylation of Keap1 disrupting the interactions
between Keap1 and Nrf2 (Figure 4) [59].
Although this has not been observed in humans to date, it is plausible that the same circuit is
also characteristic of the human cell. It is also tempting to suggest that other glutathione-S-
transferases may have the same function. At least GSTA1 [60] and GSTA4 [61] expression is,
meanwhile, subject to NRF2 regulation.
A Master Regulator of Oxidative Stress - The Transcription Factor Nrf270
Figure 4. The GSTP1 feed-forward circuit. GS-S-Keap1—S-glutathionylated Keap1.
Of importance, GSTP1 is activated by both AP-1 and NRF2. Thus, whenever AP-1 is activated,
NRF2 is released of KEAP1. This may be a mechanism of protective coupling of cellular events
because AP-1 has much more profound effects on the cellular physiology than NRF2 does.
2.5. The NOX4 feed-forward circuit
Among peculiar NRF2 targets is NOX4 [62, 63]. This protein is a part of one of NADPH oxidase
multiprotein complexes. The inherent NOX4 function is production of superoxide anion,
similarly to other Noxes. Two features of this enzyme with respect to other enzymes of the
family are that (1) NOX4 is strongly expressed in kidney where it is suggested to serve as an
oxygen sensor for controlling the erythropoietin production [64, 65], and (2) NOX4 is localized
to endoplasmic reticulum [66] and nucleus [65] in addition to cell membrane.
Barring NOX5 [67], Noxes require partners for functioning. In case of NOX4, the obligate
partner is only one—the CYBA protein (widely known as p22phox) [68]. Thus, the NOX4 feed-
forward circuit would require CYBA for functioning, and CYBA is not an NRF2 target.
However, CYBA is in fact an NF-kappaB and AP-1 target [69]. Thus, the composite NRF2/AP-1
pathway controls both enzymes necessary for the NOX4 feed-forward circuit (Figure 5).
Figure 5. The NOX4 feed-forward circuit.
Additionally, NF-kappaB is activated by pro-oxidants [40, 70–72], and DNA binding of both
AP-1 and NF-kappaB is stimulated by TXN [40, 70–73].
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3. Feed-back circuits
As seen from data above, the cellular feed-forward circuits of the NRF2/AP-1 pathway are
numerous and versatile providing the cell with required steady-state levels of the proteins,
and signal amplification upon induction of the pathway. However, as already mentioned,
hyperactive NRF2 and AP-1 are a death threat to the organism. If NRF2 causes disturbances
of tissues functioning, AP-1 is a pro-oncogenic transcription factor (JUN and FOS proteins are
also, and in some areas—ordinarily, known as c-jun and c-fos proto-oncogenes) [74, 75]. In
addition to that, NRF2 controls autophagy through SQSTM1, and also transactivates several
ABC-transporters, including ABCB1 (MDR1), ABCG2 (BCRP), ABCC2 (MRP2) and ABCC3
(MRP3) [76]—these are all major factors of carcinogenesis and cancer progression. Please note
that although autophagy suppresses malignization, once tumor turns malignant, autophagy
becomes a cancer-promoting metabolic and drug resistance-conferring trait [77].
Thus, NRF2 and AP-1 activity should be tightly controlled once activated. Several feed-back
circuits allow for that. Two of them involve factors participating in feed-forward circuits. These
circuits are the first to be discussed.
3.1. The TXN feed-back circuit
TXN localizes to cytoplasm and migrates to nucleus upon stimulation. However, the cyto-
plasmic pool of thioredoxin 1 provides the cell with antioxidant capacity. Thus, cytoplasmic
TXN inhibits pro-oxidants-induced NF-kappaB and NRF2 nuclear import [72].
Consequently, as soon as the NRF2/AP-1 pathway activation produces substantial amounts of
thioredoxin 1, TXN stabilizes KEAP1 and promotes NRF2 sequestration and degradation
(Figure 6). This works wherever KEAP1 and TXN appear, as will be discussed later.
Figure 6. The TXN feed-back circuit. Dotted line marks an indirect effect.
3.2. The NRF3/NOX4 feed-back circuit
One of the least studied, if not the worst studied, bZip proteins is the third homolog of NRF2
—NRF3. Very little is known about this transcription factor except the fact that it usually
antagonizes NRF1 and NRF2 [22, 78, 79]. Even less is known on stimuli that activate NRF3.
NRF3 knockout is known not to change the phenotype to any notable extent [80].
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However, Zhang et al. and Pepe et al. revealed that NRF3 is activated by ER stress inducers [81,
82]. Once activated, NRF3, predictably, suppresses ordinary NRF2 target genes [82]. Surpris-
ingly, in contrast to these genes, NOX4 was activated by NRF3 [82]. As NOX4 is an enzyme
localized to endoplasmic reticulum and producing superoxide anion, it is capable of oxidative
modification of inositol 1,4,5-trisphosphate receptors [83]. Once oxidized, these receptors cause
calcium efflux from endoplasmic reticulum to cytosol. This event leads to endoplasmic
reticulum stress [83].
As mentioned above, NOX4, for its functioning, requires an AP-1 target—CYBA. ER stress is
not a leading, if at all, stimulus for AP-1 activation, yet ER stress causes ROS production (during
the protein refolding period), and ROS activation is an acknowledged property of AP-1 [35].
Additionally, NRF3 heterodimerizes with AP-1 proteins FOS and FOSL1 (it was suggested by
Zhang et al. that NRF3 thus suppresses TRE-containing NRF2 targets only [81]) and is
suggested to heterodimerize with Jun proteins (Figure 7) [79, 84].
Figure 7. The NRF3/NOX4 feed-back circuit. Dashed line marks putative interaction.
The fact that NRF3 activates NOX4 also suggests that the NOX4 feed-forward circuit may
equally work for both NRF2 and AP-1.
3.3. The KEAP1 feed-back circuit
KEAP1 is the immediate antagonist of NFR2 as it sequesters it and targets it for proteasomal
degradation. In a complex experiment, Lee et al. demonstrated that murine Keap1 is another
Nrf2 target [85]. Unfortunately, no direct evidences that the same is true for humans are known
to the authors to date of preparation of this chapter. This is an extremely important issue to be
addressed in future studies. Nevertheless, at least in mice, this circuit is active and facilitates
fast Nrf2 pathway shutdown as soon as the oxidative status of the cell is normalized (Figure 8).
Interestingly, KEAP1 can be imported into the nucleus by KPNA6 [46, 60, 86]. In the nucleus,
KEAP1 acts exactly as in the cytoplasm—it binds NFE2L2 and induces its polyubiquitination
thus targeting it for degradation [46, 85].
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It means that GSK3B activity providing NRF2 nuclear export [87–89] is not even required for
KEAP1 to force NRF2 degradation. However, KEAP1 nuclear import is a tightly controlled
process. An example of the chain of events causing KEAP1 nuclear import is presented in the
next section.
Figure 8. The KEAP1 feed-back circuit.
3.4. The NF-kappaB/KEAP1 feed-back circuit
KEAP1 nuclear import stimulation is well described for the case of NF-kappaB activation.
Generally, the NF-kappaB and NRF2 pathways antagonize in several ways: NF-kappaB protein
RELA (p65) promotes HDAC3 interaction with CREBBP or MAFK thus causing local hypoa-
cetylation surrounding ARE [90]; KEAP1 promotes IKK degradation thus suppressing NF-
kappaB release from IKBs [91]; and, in turn, RELA promotes KEAP1 nuclear import [46].
Thus, whenever NF-kappaB is activated, it suppresses NFE2L2 by two mechanisms: by
inducing its nuclear sequestration by KEAP1 and by causing transcription-suppressing
epigenomic modification of the NRF2-dependent loci. In this sense, the NF-kappaB/KEAP1
circuit presented here is feed-back for the NRF2/AP-1 pathway yet feed-forward for the NF-
kappaB pathway, because less KEAP1 causes less IKK degradation consequently promoting
NF-kappaB nuclear import. This feed-forward circuit is probably disrupted by TXN, which is
NRF2-dependent (Figure 9).
Figure 9. The NF-kappaB/KEAP1 feed-back circuit.
3.5. The BACH1 feed-back circuit
In contrast to the preferentially cytoplasmic NRF2 inhibitor KEAP1, BACH1 is its nuclear
antagonist. Just as NRF2, BACH1 belongs to the bZip family, and moreover, to cap‘n’collar
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(CNC) sub-family. Thus, BACH1 and NRF2 act in a very similar manner—by heterodimerizing
with small Maf proteins [86, 92–94]. There is, however, one striking difference between the two
transcription factors: BACH1 acts only on clustered-ARE genes [49, 93], like HMOX1 [93, 95]
and NQO1 [96].
As it was discussed earlier, different NRF2 targets may response distinctly to the pathway
stimulation or release of pathway suppression. This actually may be caused by BACH1. For
example, TXNRD1 is proven to be BACH1-independent [49], while HMOX1 has quadruple
ARE [93] being subject to BACH1-induced suppression, and NQO1 has a double ARE still
being somewhat suppressed by BACH1 [96]. It appears that BACH1 functioning allows the
cell to discriminate between the NRF2 targets. It is achieved by a relatively simple mechanism:
if NRF2 activity is induced by whatever mechanism or stimulus except for pro-oxidant
exposure, BACH1 does not allow NRF2 to act on the clustered-ARE genes. In contrast, when
the cell is exposed to pro-oxidants of whatever nature, BACH1 is fast oxidized [19, 49, 86, 93,
96, 97], rapidly detaches from DNA [93, 94, 98] and readily degrades [93, 97].
At the same time, BACH1 is itself an NRF2 target and an extremely interesting one. The BACH1
locus codes for three transcript variants produced as the result of alternative transcription
initiation. Only BACH1 transcript variant 2 is NRF2-dependent: BACH1 intronic +1411 nt ARE
is functional and promotes transcription of the second intron of the gene [50]. The authors of
this discovery, Jyrkkänen et al., proposed the existence of the BACH1 feed-back circuit along
with their discovery of the functional intronic ARE [50].
The existence of the BACH1 feed-back circuit predisposes different expression dynamics of
NRF2 targets depending on their ARE structure: once the NRF2 pathway normalizes oxidative
status of the cell, newly synthesized BACH1 protein successfully outcompetes NRF2 on the
clustered-ARE loci, while allowing it to act further on non-clustered ARE genes (Figure 10).
Figure 10. The BACH1 feed-back circuit.
In one of our studies, we appeared to observe these events after we released the JUN-imposed
suppression of NRF2 in cells treated with hydrogen peroxide: in contrast non-clustered ARE
genes (FTH1, CBR3, SQSTM1), HMOX1 expression did not rise—probably because BACH1,
being a non-clustered ARE gene, had increased expression in these those settings [34].
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3.6. The 26S proteasome/NRF2 feed-back circuit
Once polyubiquitinated, NRF2 is degraded by 26S proteasome [86]. Proteasome inhibitors
suppress the degradation of NRF2 and stimulate its nuclear import [99].
At the same time, as shown in mice, Nrf2 controls at least eight genes of proteasomal proteins:
Psma1, Psma4, Psmb3, Psmb5, Psmb6, Psmc1, Psmc3 and Psmd14 (Figure 11) [2].
Figure 11. The 26S proteasome/NRF2 feed-back circuit.
To date of preparation of the chapter, no similar results obtained from studies on human cells
have been published. Nevertheless, considering the biological significance of the 26S protea-
some, it is not an unfair assumption that the same genes are probably controlled by NRF2 in
humans.
Notably, even in human cells, AP-1 controls expression of interferon gamma [100], which, in
turn, transactivates PSME1 [101] and PSME2 [102] subunit genes of the 26S proteasome.
Thus, NRF2 pathway activation facilitates NRF2 proteasomal degradation once KEAP1 is re-
enabled to sequester NRF2. At least, this system works in mice, and probably in humans, too,
especially since two Psme genes are under the NRF2/AP-1 pathway control.
3.7. The MIR-144 feed-back circuit
One of numerous NRF2-antagonizing miRNAs, MIR-144, is expressed under control of AP-1
[103]. This miRNA not merely blocks translation of NRF2, but rather degrades the NRF2
mRNA [104, 105].
3.8. The mitochondrial bidirectional circuit
Being regulated by reactive oxygen species and signaling background of the cell, the NRF2/
AP-1 pathway depends on mitochondrial function, including their vast signaling activity [106].
Surprisingly, the NRF2/AP-1 pathway has been found to modulate mitochondrial biogenesis
by two mechanisms. The first one has direct experimental evidences: NRF2 is a transcriptional
regulator of NRF1—nuclear respiratory factor (which is not to be confused with NFE2L1, an
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NRF2 homolog, also known and referred to as NRF1 in this chapter) [107]. NRF1, in turn,
controls a battery of nuclear genes required for mitochondrial biogenesis and function [107].
The second mechanism has not been observed in direct experiments and is related to the fact
that the NRF1 protein is also controlled by estrogen receptors—a distinct family of transcrip-
tion factors [108]. However, it is well-known that estrogen receptors act in an intimate
collaboration with AP-1 proteins [109, 110]. For example, FOS alone is required for expression
of 37% of estrogen receptors target genes [111]. Even though the mitochondrial biogenesis-
related targets of the estrogen receptors may not fall into the AP-1-dependent category, which
is to be addressed in the future, there is another doubtless interaction between the estrogen
receptors and the NRF2/AP-1 pathway. The already discussed NRF2/AP-1 target, TXNRD1 is
a strong promoter of transactivatory function of the estrogen receptors [111], thus the NRF2/
AP-1 pathway positively regulates estrogen receptors function, while estrogen receptors
facilitate mitochondria biogenesis.
Although mitochondrial biogenesis eventually leads to increased ROS generation, this circuit
is unlikely to be purely or even mostly feed-forward. Rather, this circuit is bidirectional with
strong feed-back action because the outer mitochondrial membrane carries the PGAM5
protein. PGAM5, in turn, tethers the NRF2-KEAP1 complexes to mitochondria and acts as a
powerful suppressor of the NRF2-dependent expression (Figure 12) [106, 112].
Figure 12. The mitochondrial bi-directional circuit. NRF1 here is nuclear respiratory factor 1.
Thus, the more mitochondria, the more KEAP1-NRF2 complexes are likely to be bound to
them, leading to decreased availability of NRF2 to nucleus. Unfortunately, it is not known to
date how PGAM5 expression is controlled with relation to mitochondria biogenesis—the
protein is poorly studied.
It is worth noting that the PGAM5/KEAP1-NRF2 system is suggested to represent a stand-by
alarm inducible by changes in mitochondrial function [106, 112]. PGAM5 also appears to
stimulate mitophagy as a part of cellular defense against excessive reactive oxygen species
[113]. It could be suggested that this function of PGAM5 is directly related to its sequestering
of NRF2 with subsequent release of it upon mitochondrial dysfunction: NRF2 controls
expression of SQSTM1 and SESN2, two factors of autophagy/mitophagy already discussed
above [32, 114].
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3.9. The NRF2 bidirectional circuit
NRF2 expression is known to respond to stimuli that activate the NRF2/AP-1 pathway [34, 51,
115]. We and others observed that, for reasons still to be revealed, NRF2 had a humped
expression curve when different cells had been treated with various pro-oxidant substances
[34, 115]. It is possible that this is related to the AP-1/TXN/NRF2 bidirectional circuit. It is
tempting to suggest that this is caused by AP-1 components that are expressed with different
dynamics upon stimulation.
For example, Siriani et al. demonstrated, that angiotensin II, over the same period of treatment,
induced 300-fold change in expression of FOS, 500-fold change in expression of FOSB, 2-fold
change in expression of FOSL1 and FOSL2, 4-fold change in expression of JUN, 14-fold change
in expression of JUNB and 2-fold change in expression of JUND. The same was also fair for the
classical AP-1 inducer—TPA: it caused 194-fold change in expression of FOS, 65-fold change
in expression of FOSB, 2-fold change in expression of FOSL1, 2-fold change in expression of
JUN and JUND, and 9-fold change in expression of JUNB [116].
Since overflow inhibition is characteristic of AP-1 [117], and competition of bZip dimers is a
must, it is possible that alterations in ratio of AP-1 components controlling NRF2 expression
lead to its humped dosage-expression curve.
This circuit cannot be considered purely feed-back, because before certain threshold, the
stimulus activates NRF2 expression. Yet, this character of expression of NRF2 is not entirely of
feed-forward nature, and this is discussed in the next, last, section of this chapter.
3.10. The truncated NRF2 feed-back circuit
NRF2 is cleaved into a truncated form named truncated NRF2, or tNRF2, by Ice family-like
caspases [118]. Just as the full-length protein, tNRF2 enters nucleus, but there it antagonizes
the normal NRF2 and suppresses ARE-containing loci [19, 118].
4. Conclusion
Although studying the NRF2/AP-1 pathway targets is an extremely complex task due to their
plentitude, experimental evidences suggest that this relatively small, with respect to the
regulatory proteins, pathway has enormous number of feed-forward and feed-back circuits,
some of them being bidirectional.
Some evidences demonstrated directly that these circuits contribute to either fast activation or
quenching of the pathway. For other circuits, no such testing has ever been performed.
Nevertheless, the existing data unambiguously point out that these circuits are an essential
feature of the NRF2/AP-1 pathway. These circuits must be accounted in all applications—
starting from cell sensor-based pharmacological screening techniques [119, 120] and ending
with therapeutical research and development [121].
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